GlassScriptPhysician profile
Cara M Shepherd
NPI 1467581165
$2,300.60
in general payments reported to CMS, 2019-2025
20 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $521 · 2023: $640 · 2024: $545 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,207 · Education: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,206.58 |
| Education | $215.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.28 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $355.58 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $247.68 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $221.90 | 2021-2024 | Ilumya |
| Genzyme Corporation | $123.11 | 2021-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $99.34 | 2021-2024 | Jublia, Cabtreo, Arazlo |
| Pfizer INC. | $98.96 | 2021-2024 | |
| Incyte Corporation | $94.63 | 2021-2025 | Opzelura |
| Janssen Biotech, INC. | $73.02 | 2021-2023 | Tremfya |
| Almirall LLC | $58.85 | 2021-2022 | |
| Lilly USA, LLC | $57.39 | 2022-2023 | Taltz, Olumiant |
| Regeneron Healthcare Solutions, INC. | $56.55 | 2024 | Dupixent |
| Ucb, INC. | $50.54 | 2021-2022 | |
| Leo Pharma INC. | $48.69 | 2021-2023 | Adbry |
| Galderma Laboratories, L.P. | $30.36 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.33 | 2021-2022 | |
| Biofrontera INC. | $18.00 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Organon LLC | $16.66 | 2025 | Vtama |
| Amgen INC. | $15.87 | 2021 | |
| Journey Medical Corporation | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cara Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.